CH555845A - Verfahren zur herstellung von oxazolidinonen und deren verwendung. - Google Patents

Verfahren zur herstellung von oxazolidinonen und deren verwendung.

Info

Publication number
CH555845A
CH555845A CH764267A CH764267A CH555845A CH 555845 A CH555845 A CH 555845A CH 764267 A CH764267 A CH 764267A CH 764267 A CH764267 A CH 764267A CH 555845 A CH555845 A CH 555845A
Authority
CH
Switzerland
Prior art keywords
oxazolidinone
methyl
compounds
formula
ethyl
Prior art date
Application number
CH764267A
Other languages
German (de)
English (en)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CH555845A publication Critical patent/CH555845A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH764267A 1966-06-13 1967-05-30 Verfahren zur herstellung von oxazolidinonen und deren verwendung. CH555845A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55687266A 1966-06-13 1966-06-13
US75537068A 1968-08-26 1968-08-26

Publications (1)

Publication Number Publication Date
CH555845A true CH555845A (de) 1974-11-15

Family

ID=27071276

Family Applications (1)

Application Number Title Priority Date Filing Date
CH764267A CH555845A (de) 1966-06-13 1967-05-30 Verfahren zur herstellung von oxazolidinonen und deren verwendung.

Country Status (11)

Country Link
US (2) US3455941A (da)
BE (1) BE699845A (da)
CH (1) CH555845A (da)
DE (1) DE1695638A1 (da)
DK (1) DK127066B (da)
ES (1) ES341733A1 (da)
FR (1) FR6693M (da)
GB (1) GB1167392A (da)
IL (1) IL28125A (da)
NL (2) NL6708113A (da)
SE (1) SE325576B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856962A (en) * 1973-07-10 1974-12-24 R Alphin Anti-inflammatory agents
US3895021A (en) * 1973-09-04 1975-07-15 Smithkline Corp N-heterocyclic pulvinic acid amides
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives
US5086055A (en) * 1990-12-24 1992-02-04 A. H. Robins Company, Incorporated Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
US5162322A (en) * 1991-03-06 1992-11-10 A. H. Robbins Company, Incorporated Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones
JPH09504272A (ja) * 1993-09-15 1997-04-28 メルク シヤープ エンド ドーム リミテツド ドーパミンアンタゴニストとしてのイミダゾロン及びオキサゾロン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2537854A (en) * 1949-07-08 1951-01-09 Hoffmann La Roche Tetrahydropyridines and method of manufacture
US3085093A (en) * 1961-09-25 1963-04-09 Warner Lambert Pharmaceutical 1, 6-bis(2, 2, 6, 6-tetramethylpiperidino)-2, 4-hexadiyne
DE1210874B (de) * 1961-12-14 1966-02-17 Degussa Verfahren zur Herstellung von Diarylaminoderivaten von Arylaminoalkanen

Also Published As

Publication number Publication date
ES341733A1 (es) 1968-07-01
NL6708113A (da) 1967-12-14
IL28125A (en) 1972-07-26
BE699845A (da) 1967-11-16
US3455941A (en) 1969-07-15
DK127066B (da) 1973-09-17
SE325576B (da) 1970-07-06
NL130094C (da) 1900-01-01
GB1167392A (en) 1969-10-15
DE1695638A1 (de) 1972-03-02
FR6693M (da) 1969-02-10
US3513236A (en) 1970-05-19

Similar Documents

Publication Publication Date Title
DE1595915C3 (de) Pyrrolidinderivate
DE69623631T2 (de) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe
DE3688827T2 (de) Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
DE3001328C2 (da)
DE69023928T2 (de) DIAMINVERBINDUNGEN UND ARZNEIMITTEL GEGEN CEREBRALE STöRUNGEN DIE DIESE ENTHALTEN.
DE69329894T2 (de) Arylamidderivate
DE3883387T2 (de) Bis(methylendioxy)biphenyl-Verbindungen.
DE2065636A1 (de) Neue tricyclische verbindungen
DE2807623C2 (de) 2-Phenoxyphenyl-pyrrolidinderivate, deren Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2719211C3 (de) 1-(2-Phenylamino-äthyl)-4-(N-phenyl-N-propionylamino)-piperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH631164A5 (de) Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin.
DE69014064T2 (de) Benzopyranon-beta-D-thioxyloside, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE2006978B2 (de) N- [H3-Trifluormethyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2618999C2 (de) 1-{[5-(4-Hydroxy-2H-1,2-benzothiazin-3-yl)-1,2.4-oxadiazol-3-yl]methyl}-äthanon-S,S-dioxide, Verfahren zu ihrer Herstellung sowie Verfahren zu ihrer Weiterverarbeitung
CH555845A (de) Verfahren zur herstellung von oxazolidinonen und deren verwendung.
DE69119509T2 (de) Benzhydryloxyethylpiperidyl-Derivate aliphatischer Carbonsäuren und ihre Anwendung zur Behandlung von Allergien und Asthma
DE3025436A1 (de) Neue alpha -phenyl-2-pyrrolidinmethanol-derivate und ihre salze, ihr herstellungsverfahren, ihre verwendung als arzneimittel und die diese enthaltenden zusammensetzungen
DE2348973C3 (de) 1 -(m-Trifluormethylphenyl)-4-propyIpiperazin-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69110217T2 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
DE2017256A1 (de) l-Carbamoyl-3-pheny!pyrrolidine und Verfahren zu deren Herstellung
DE2517020A1 (de) Alkanolaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH610330A5 (en) Process for the preparation of novel ergopeptins
DE2907379A1 (de) Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2428200A1 (de) Essigsaeurederivate, verfahren zu deren herstellung und diese derivate enthaltende arzneimittel
DE1620746A1 (de) Verfahren zur Herstellung von Phenothiazin-Derivaten

Legal Events

Date Code Title Description
PL Patent ceased